Mixed-Backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Mixed-backbone oligonucleotides containing alternative phosphorothioate and phosphodiester linkages in the 2'-O-methylribonucleosides segment show increased affinity with complementary targets, increased stability towards nucleases in vitro and in vivo, and reduced phosphorothioate-related prolongation of partial thromboplastin time compared to phosphorothioate oligodeoxynucleotides, thereby providing antisense agents with reduced side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, 2′-O-MeRNA and other 2′-O-alkyl-derivatized oligomers bind more tightly to complementary RNA sequences than do analogous DNA oligomers”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [46]
In the citing paper
“and have improved resistance to degradation by nucleases, reducing the need for phosphorothioate linkages and improving the selectivity of antisense effects (45, 46)”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [46]
Citations
Cites
Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., & Freier, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85268-7 · Cited by 778
Antisense oligonucleotides: towards clinical trials
Agrawal, S. (1996) · Trends in Biotechnology · doi:10.1016/0167-7799(96)10053-6 · Cited by 265
Self-citationEffect of different chemically modified oligodeoxynucleotides on immune stimulation
Zhao, Q., Temsamani, J., Iadarola, P. L., Jiang, Z., & Agrawal, S. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02177-9 · Cited by 176
Self-citationAltmann, K.-H., Dean, N. M., Fabbro, D., Freier, S. M., Geiger, T., Häner, R., Hüsken, D., Martin, P., Monia, B. P., Müller, M., et al. (1996) · CHIMIA · doi:10.2533/chimia.1996.168 · Cited by 169
A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth
Nesterova, M., & Cho‐Chung, Y. S. (1995) · Nature Medicine · doi:10.1038/nm0695-528 · Cited by 138
GILES, R. V., SPILLER, D. G., & TIDD, D. M. (1995) · Antisense Research and Development · doi:10.1089/ard.1995.5.23 · Cited by 108
In vivo stability, disposition and metabolism of a “hybrid” oligonucleotide phosphorothioate in rats
Zhang, R., Lu, Z., Zhao, H., Zhang, X., Diasio, R. B., Habuš, I., Jiang, Z., Iyer, R. P., Dong, Y. J., & Agrawal, S. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00159-w · Cited by 97
Self-citationMixed Backbone Oligonucleotides: Improvement in Oligonucleotide-induced Toxicity In Vivo
Agrawal, S., & Zhao, Q. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.135 · Cited by 83
Self-citationMetelev, V., Lisziewicz, J., & Agrawal, S. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80842-8 · Cited by 65
Self-citationEffects of synthetic oligonucleotides on human complement and coagulation∗
Shaw, D. R., Rustagi, P. K., Kandimalla, E. R., Manning, A. N., Jiang, Z., & Agrawal, S. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00091-9 · Cited by 48
Self-citation
Research works printed but not linked: 2
- Agrawal, 1990, 87, 1401
- Agrawal, 1997, 94, 2620
Cited by
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
Wahlestedt, C., Salmi, P., Good, L., Kela, J., Johnsson, T., Hökfelt, T., Broberger, C., Porreca, F., Lai, J., Ren, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5633 · Cited by 520
Herbert, B.-S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., & Corey, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14276 · Cited by 539
Recent progress in non-native nucleic acid modifications
McKenzie, L. K., El-Khoury, R., Thorpe, J. D., Damha, M. J., & Hollenstein, M. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01430c · Cited by 300
Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides
Agrawal, S. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00141-4 · Cited by 179
Self-citationAntisense and siRNA as agonists of Toll-like receptors
Agrawal, S., & Kandimalla, E. R. (2004) · Nature Biotechnology · doi:10.1038/nbt1042 · Cited by 144
“Increased metabolic stability of second-generation antisense allows less frequent dosing and also permits oral deliver”
Self-citation
Metadata
- Authors
- Zhou, W., & Agrawal, S.
- Venue
- Bioorganic & Medicinal Chemistry Letters
- Publisher
- Elsevier BV
- Published
- 1998-11
- Volume
- 8
- Issue
- 22
- Pages
- 3269-3274
- ISSN
- 0960-894X (ISSN-L)
- OpenAlex
- W1992368170
- Cited by
- 41
- References
- 15
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 2 · 2021: 2 · 2019: 1 · 2013: 1 · 2012: 1
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Bioorganic & Medicinal Chemistry Letters (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Keywords
- antisense oligonucleotides, phosphorothioate linkages, phosphodiester linkage, nuclease resistance, activated partial thromboplastin time, oligonucleotide stability
- MeSH terms
- Drug Stability, Humans, Partial Thromboplastin Time, Structure-Activity Relationship, Thionucleotides, Oligonucleotides, Antisense
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mixed-Backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects. https://app.cochat.ai/papers/10.1016/s0960-894x(98)00591-5
- The paper
- Zhou, W., & Agrawal, S. (1998). Mixed-Backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/s0960-894x(98)00591-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.